Correlation Between Centessa Pharmaceuticals and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Acrivon Therapeutics,.
Diversification Opportunities for Centessa Pharmaceuticals and Acrivon Therapeutics,
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Centessa and Acrivon is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Acrivon Therapeutics,
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.77 times more return on investment than Acrivon Therapeutics,. However, Centessa Pharmaceuticals PLC is 1.3 times less risky than Acrivon Therapeutics,. It trades about 0.18 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest 1,589 in Centessa Pharmaceuticals PLC on September 3, 2024 and sell it today you would earn a total of 202.00 from holding Centessa Pharmaceuticals PLC or generate 12.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Acrivon Therapeutics, |
Centessa Pharmaceuticals and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Acrivon Therapeutics,
The main advantage of trading using opposite Centessa Pharmaceuticals and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.The idea behind Centessa Pharmaceuticals PLC and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Acrivon Therapeutics, vs. DiaMedica Therapeutics | Acrivon Therapeutics, vs. Lyra Therapeutics | Acrivon Therapeutics, vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |